This CD4/CD8 imbalance, seen in response to natural infection and vaccination (4, 43), might be due to the inactivated nature of CoronaVac® and the aluminum hydroxide adjuvant favoring CD4+ over CD8+ T-cell (44). This evidence concerns the gene CD8A and infection.